Enlightening the malaria parasite life cycle: Bioluminescent Plasmodium in fundamental and applied research

Frontiers in Microbiology

Volumn 6, Issue MAY, 2015, Pages

  Siciliano, Giulia ^a   Alano, Pietro ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Bioluminescence; Cell based screening assays; In vivo imaging; Malaria; Plasmodium; Reporter genes

Indexed keywords

BIOLUMINESCENCE; GAMETOCYTE; GENE EXPRESSION; GENE MUTATION; HUMAN; LIFE CYCLE; LUCIFERASE ASSAY; MALARIA; MEROZOITE; NONHUMAN; PLASMODIUM; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZONT; SHORT SURVEY; SPOROZOITE;

HEXAPODA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PROTOZOA; RODENTIA; VERTEBRATA;

EID: 84931262681     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00391     Document Type: Short Survey

References (82)

1. Adjalley, S. H., Johnston, G. L., Li, T., Eastman, R. T., Ekland, E. H., Eappen, A. G., et al. (2011). Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc. Natl. Acad. Sci. U.S.A. 108, E1214-E1223. doi: 10.1073/pnas.1112037108.
2. Amante, F. H., Stanley, A. C., Randall, L. M., Zhou, Y., Haque, A., McSweeney, K., et al. (2007). A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am. J. Pathol. 171, 548-559. doi: 10.2353/ajpath.2007.061033.
3. Annoura, T., Chevalley, S., Janse, C. J., Franke-Fayard, B., and Khan, S. M. (2013). Quantitative analysis of Plasmodium berghei liver stages by bioluminescence imaging. Methods Mol. Biol. 923, 429-443. doi: 10.1007/978-1-62703-026-7_30.
4. Annoura, T., Ploemen, I. H., van Schaijk, B. C., Sajid, M., Vos, M. W., van Gemert, G. J., et al. (2012). Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates. Vaccine. 30, 2662-2670. doi: 10.1016/j.vaccine.2012.02.010.
5. Azevedo, M. F., and del Portillo, H. A. (2007). Promoter regions of Plasmodium vivax are poorly or not recognized by Plasmodium falciparum. Malar. J. 6, 20. doi: 10.1186/1475-2875-6-20.
6. Azevedo, M. F., Nie, C. Q., Elsworth, B., Charnaud, S. C., Sanders, P. R., Crabb, B. S., et al. (2014). Plasmodium falciparum transfected with ultra bright NanoLuc luciferase offers high sensitivity detection for the screening of growth and cellular trafficking inhibitors. PLoS ONE 9:e112571. doi: 10.1371/journal.pone.0112571.
7. Bischoff, E., Guillotte, M., Mercereau-Puijalon, O., and Bonnefoy, S. (2000). A member of the Plasmodium falciparum Pf60 multigene family codes for a nuclear protein expressed by read through of an internal stop codon. Mol. Microbiol. 35, 1005-1016. doi: 10.1046/j.1365-2958.2000.01788.x.
8. Braks, J., Aime, E., Spaccapelo, R., Klop, O., Janse, C. J., and Franke-Fayard, B. (2013). Bioluminescence imaging of P. berghei schizont sequestration in rodents. Methods Mol. Biol. 923, 353-368. doi: 10.1007/978-1-62703-026-7_25.
9. Burghaus, P. A., and Lingelbach, K. (2001). Luciferase, when fused to an N-terminal signal peptide, is secreted from transfected Plasmodium falciparum and transported to the cytosol of infected erythrocytes. J. Biol. Chem. 276, 26838-26845. doi: 10.1074/jbc.M100111200.
10. Calderwood, M. S., Gannoun-Zaki, L., Wellems, T. E., and Deitsch, K. W. (2003). Plasmodium falciparum var genes are regulated by two regions with separate promoters, one upstream of the coding region and a second within the intron. J. Biol. Chem. 278, 34125-34132. doi: 10.1074/jbc.M213065200.
11. Cevenini, L., Camarda, G., Michelini, E., Siciliano, G., Calabretta, M. M., Bona, R., et al. (2014). Multicolor bioluminescence boosts malaria research: quantitative dual-color assay and single-cell imaging in Plasmodium falciparum parasites. Anal. Chem. 86, 8814-8821. doi: 10.1021/ac502098w.
12. Che, P., Cui, L., Kutsch, O., Cui, L., and Li, Q. (2012). Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery. Assay Drug Dev. Technol. 10, 61-68. doi: 10.1089/adt.2011.0378.
13. Claser, C., Malleret, B., Gun, S. Y., Wong, A. Y., Chang, Z. W., Teo, P., et al. (2011). CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS ONE 6:e18720. doi: 10.1371/journal.pone.0018720.
14. Cui, L., Miao, J., Wang, J., Li, Q., and Cui, L. (2008). Plasmodium falciparum: development of a transgenic line for screening antimalarials using firefly luciferase as the reporter. Exp. Parasitol. 120, 80-87. doi: 10.1016/j.exppara.2008.05.003.
15. de Azevedo, M. F., Gilson, P. R., Gabriel, H. B., Simões, R. F., Angrisano, F., Baum, J., et al. (2012). Systematic analysis of FKBP inducible degradation domain tagging strategies for the human malaria parasite Plasmodium falciparum. PLoS ONE 7:e40981. doi: 10.1371/journal.pone.0040981.
16. Deitsch, K. W., del Pinal, A., and Wellems, T. E. (1999). Intra-cluster recombination and var transcription switches in the antigenic variation of Plasmodium falciparum. Mol. Biochem. Parasitol. 101, 107-116. doi: 10.1016/S0166-6851(99)00062-6.
17. de Koning-Ward, T. F., Sperança, M. A., Waters, A. P., and Janse, C. J. (1999). Analysis of stage specificity of promoters in Plasmodium berghei using luciferase as a reporter. Mol. Biochem. Parasitol. 100, 141-146. doi: 10.1016/S0166-6851(99)00042-0.
18. Delves, M. J., and Sinden, R. E. (2010). A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies. Malar. J. 9, 35. doi: 10.1186/1475-2875-9-35.
19. Derbyshire, E. R., Prudêncio, M., Mota, M. M., and Clardy, J. (2012). Liver-stage malaria parasites vulnerable to diverse chemical scaffolds. Proc. Natl. Acad. Sci. U.S.A. 109, 8511-8516. doi: 10.1073/pnas.1118370109.
20. Ekland, E. H., Schneider, J., and Fidock, D. A. (2011). Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches. FASEB J. 25, 3583-3593. doi: 10.1096/fj.11-187401.
21. Epp, C., Raskolnikov, D., and Deitsch, K. W. (2008). A regulatable transgene expression system for cultured Plasmodium falciparum parasites. Malar. J. 7, 86. doi: 10.1186/1475-2875-7-86.
22. Fidock, D. A. (2010). Drug discovery: priming the antimalarial pipeline. Nature 465, 297-298. doi: 10.1038/465297a.
23. Fernandez-Becerra, C., de Azevedo, M. F., Yamamoto, M. M., and del Portillo, H. A. (2003). Plasmodium falciparum: new vector with bi-directional promoter activity to stably express transgenes. Exp. Parasitol. 103, 88-91. doi: 10.1016/S0014-4894(03)00065-1.
24. Frank, M., Dzikowski, R., Costantini, D., Amulic, B., Berdougo, E., and Deitsch, K. (2006). Strict pairing of var promoters and introns is required for var gene silencing in the malaria parasite Plasmodium falciparum. J. Biol. Chem. 281, 9942-9952 doi: 10.1074/jbc.M513067200.
25. Franke-Fayard, B., Djokovic, D., Dooren, M. W., Ramesar, J., Waters, A. P., Falade, M. O., et al. (2008). Simple and sensitive antimalarial drug screening in vitro and in vivo using transgenic luciferase expressing Plasmodium berghei parasites. Int. J. Parasitol. 38, 1651-1662. doi: 10.1016/j.ijpara.2008.05.012.
26. Franke-Fayard, B., Janse, C. J., Cunha-Rodrigues, M., Ramesar, J., Büscher, P., Que, I., et al. (2005). Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc. Natl. Acad. Sci. U.S.A. 102, 11468-11473. doi: 10.1073/pnas.0503386102.
27. Franke-Fayard, B., Waters, A. P., and Janse, C. J. (2006). Real-time in vivo imaging of transgenic bioluminescent blood stages of rodent malaria parasites in mice. Nat. Protoc. 1, 476-485. doi: 10.1038/nprot.2006.69.
28. Golightly, L. M., Mbacham, W., Daily, J., and Wirth, D. F. (2000). 3' UTR elements enhance expression of Pgs28, an ookinete protein of Plasmodium gallinaceum. Mol. Biochem. Parasitol. 105, 61-70. doi: 10.1016/S0166-6851(99)00165-6.
29. Goonewardene, R., Daily, J., Kaslow, D., Sullivan, T. J., Duffy, P., Carter, R., et al. (1993). Transfection of the malaria parasite and expression of firefly luciferase. Proc. Natl. Acad. Sci. U.S.A. 90, 5234-5236. doi: 10.1073/pnas.90.11.5234.
30. Gopalakrishnan, A. M., and López-Estraño, C. (2010). Role of cis-regulatory elements on the ring-specific hrp3 promoter in the human parasite Plasmodium falciparum. Parasitol Res. 106, 833-845. doi: 10.1007/s00436-010-1738-9.
31. Hasenkamp, S., Russell, K. T., and Horrocks, P. (2012). Comparison of the absolute and relative efficiencies of electroporation-based transfection protocols for Plasmodium falciparum. Malar. J. 11, 210. doi: 10.1186/1475-2875-11-210.
32. Hasenkamp, S., Russell, K. T., Ullah, I., and Horrocks, P. (2013a). Functional analysis of the 5' untranslated region of the phosphoglutamase 2 transcript in Plasmodium falciparum. Acta Trop. 127, 69-74. doi: 10.1016/j.actatropica.2013.03.007.
33. Hasenkamp, S., Sidaway, A., Devine, O., Roye, R., and Horrocks, P. (2013b). Evaluation of bioluminescence-based assays of anti-malarial drug activity. Malar. J. 12, 58. doi: 10.1186/1475-2875-12-58.
34. Helm, S., Lehmann, C., Nagel, A., Stanway, R. R., Horstmann, S., Llinas, M., et al. (2010). Identification and characterization of a liver stage-specific promoter region of the malaria parasite Plasmodium. PLoS ONE 5:e13653. doi: 10.1371/journal.pone.0013653.
35. Horrocks, P., and Kilbey, B. J. (1996). Physical and functional mapping of the transcriptional start sites of Plasmodium falciparum proliferating cell nuclear antigen. Mol. Biochem. Parasitol. 82, 207-215. doi: 10.1016/0166-6851(96)02737-5.
36. Imai, T., Iwawaki, T., Akai, R., Suzue, K., Hirai, M., Taniguchi, T., et al. (2014). Evaluating experimental cerebral malaria using oxidative stress indicator OKD48 mice. Int. J. Parasitol. 44, 681-685. doi: 10.1016/j.ijpara.2014.06.002.
37. Kaushansky, A., Mikolajczak, S. A., Vignali, M., and Kappe, S. H. (2014). Of men in mice: the success and promise of humanized mouse models for human malaria parasite infections. Cell Microbiol. 16, 602-611. doi: 10.1111/cmi.12277.
38. Khan, T., van Brummelen, A. C., Parkinson, C. J., and Hoppe, H. C. (2012). ATP and luciferase assays to determine the rate of drug action in in vitro cultures of Plasmodium falciparum. Malar. J. 11, 369. doi: 10.1186/1475-2875-11-369.
39. Kolevzon, N., Nasereddin, A., Naik, S., Yavin, E., and Dzikowski, R. (2014). Use of peptide nucleic acids to manipulate gene expression in the malaria parasite Plasmodium falciparum. PLoS ONE 9:e86802. doi: 10.1371/journal.pone.0086802.
40. Lacrue, A. N., Sáenz, F. E., Cross, R. M., Udenze, K. O., Monastyrskyi, A., Stein, S., et al. (2013). 4(1H)-Quinolones with liver stage activity against Plasmodium berghei. Antimicrob. Agents. Chemother. 57, 417-424. doi: 10.1128/AAC.00793-12.
41. Li, Q., O'Neil, M., Xie, L., Caridha, D., Zeng, Q., Zhang, J., et al. (2014). Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections. Malar. J. 13, 141. doi: 10.1186/1475-2875-13141.
42. Lin, J. W., Sajid, M., Ramesar, J., Khan, S. M., Janse, C. J., and Franke-Fayard, B. (2013). Screening inhibitors of P. berghei blood stages using bioluminescent reporter parasites. Methods Mol. Biol. 923, 507-522. doi: 10.1007/978-1-62703-026-7_35.
43. López-Estraño, C., Gopalakrishnan, A. M., Semblat, J. P., Fergus, M. R., Mazier, D., and Haldar, K. (2007). An enhancer-like region regulates hrp3 promoter stage-specific gene expression in the human malaria parasite Plasmodium falciparum. Biochim. Biophys. Acta 1769, 506-513. doi: 10.1016/j.bbaexp.2007.04.009.
44. Lucantoni, L., Duffy, S., Adjalley, S. H., Fidock, D. A., and Avery, V. M. (2013). Identification of MMV malaria box inhibitors of Plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay. Antimicrob. Agents Chemother. 57, 6050-6062. doi: 10.1128/AAC.00870-13.
45. Lucumi, E., Darling, C., Jo, H., Napper, A. D., Chandramohanadas, R., Fisher, N., et al. (2010). Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay. Antimicrob. Agents Chemother. 54, 3597-3604. doi: 10.1128/AAC.00431-10.
46. Mair, G. R., Braks, J. A., Garver, L. S., Wiegant, J. C., Hall, N., Dirks, R. W., et al. (2006). Regulation of sexual development of Plasmodium by translational repression. Science 313, 667-669 doi: 10.1126/science.1125129.
47. Manzoni, G., Briquet, S., Risco-Castillo, V., Gaultier, C., Topçu, S., Ivãnescu, M. L., et al. (2014). A rapid and robust selection procedure for generating drug-selectable marker-free recombinant malaria parasites. Sci. Rep. 4, 4760. doi: 10.1038/srep04760.
48. Marcsisin, S. R., Sousa, J. C., Reichard, G. A., Caridha, D., Zeng, Q., Roncal, N., et al. (2014). Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds. Malar. J. 13, 2. doi: 10.1186/1475-2875-13-2.
49. Militello, K. T., Dodge, M., Bethke, L., and Wirth, D. F. (2004). Identification of regulatory elements in the Plasmodium falciparum genome. Mol. Biochem. Parasitol. 134, 75-88. doi: 10.1016/j.molbiopara.2003.11.004.
50. Militello, K. T., and Wirth, D. F. (2003). A new reporter gene for transient transfection of Plasmodium falciparum. Parasitol. Res. 89, 154-157. doi: 10.1007/s00436-002-0721-5.
51. Miller, J. L., Murray, S., Vaughan, A. M., Harupa, A., Sack, B., Baldwin, M., et al. (2013). Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii. PLoS ONE 8:e60820. doi: 10.1371/journal.pone.0060820.
52. Miller, L. H., Baruch, D. I., Marsh, K., and Doumbo, O. K. (2002). The pathogenic basis of malaria. Nature 415, 673-679. doi: 10.1038/415673a.
53. Milner, D. A. Jr., Whitten, R. O., Kamiza, S., Carr, R., Liomba, G., Dzamalala, C., et al. (2014). The systemic pathology of cerebral malaria in African children. Front. Cell Infect Microbiol. 4:104. doi: 10.3389/fcimb.2014.00104.
54. Myrick, A., Munasinghe, A., Patankar, S., and Wirth, D. F. (2003). Mapping of the Plasmodium falciparum multidrug resistance gene 5'-upstream region, and evidence of induction of transcript levels by antimalarial drugs in chloroquine sensitive parasites. Mol. Microbiol. 49, 671-683. doi: 10.1046/j.1365-2958.2003.03597.x.
55. Muhle, R. A., Adjalley, S., Falkard, B., Nkrumah, L. J., Muhle, M. E., and Fidock, D. A. (2009). A var gene promoter implicated in severe malaria nucleates silencing and is regulated by 3' untranslated region and intronic cis-elements. Int. J. Parasitol. 39, 1425-1439. doi: 10.1016/j.ijpara.2009.05.001.
56. Mwakingwe, A., Ting, L. M., Hochman, S., Chen, J., Sinnis, P., and Kim, K. (2009). Non-invasive real-time monitoring of liver-stage development of bioluminescent Plasmodium parasites. J. Infect. Dis. 200, 1470-1478. doi: 10.1086/606115.
57. Oguariri, R. M., Dunn, J. M., and Golightly, L. M. (2006). 3' gene regulatory elements required for expression of the Plasmodium falciparum developmental protein, Pfs25. Mol. Biochem. Parasitol. 146, 163-172. doi: 10.1016/j.molbiopara.2005.12.004.
58. Ozwara, H., van der Wel, A., Kocken, C. H., and Thomas, A. W. (2003). Heterologous promoter activity in stable and transient Plasmodium knowlesi transgenes. Mol. Biochem. Parasitol. 130, 61-64. doi: 10.1016/S0166-6851(03)00141-5.
59. Pasini, E. M., Braks, J. A., Fonager, J., Klop, O., Aime, E., Spaccapelo, R., et al. (2013). Proteomic and genetic analyses demonstrate that Plasmodium berghei blood stages export a large and diverse repertoire of proteins. Mol. Cell. Proteomics 12, 426-448. doi: 10.1074/mcp.M112.021238.
60. Patakottu, B. R., Singh, P. K., Malhotra, P., Chauhan, V. S., and Patankar, S. (2012). In vivo analysis of translation initiation sites in Plasmodium falciparum. Mol. Biol. Rep. 39, 2225-2232. doi: 10.1007/s11033-011-0971-3.
61. Ploemen, I., Behet, M., Nganou-Makamdop, K., van Gemert, G. J., Bijker, E., Hermsen, C., et al. (2011). Evaluation of immunity against malaria using luciferase-expressing Plasmodium berghei parasites. Malar. J. 10, 350. doi: 10.1186/1475-2875-10-350.
62. Ploemen, I. H., Chakravarty, S., van Gemert, G. J., Annoura, T., Khan, S. M., Janse, C. J., et al. (2013). Plasmodium liver load following parenteral sporozoite administration in rodents. Vaccine. 31, 3410-3416. doi: 10.1016/j.vaccine.2012.09.080.
63. Ploemen, I. H., Prudêncio, M., Douradinha, B. G., Ramesar, J., Fonager, J., van Gemert, G. J., et al. (2009). Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging. PLoS ONE 4:e7881. doi: 10.1371/journal.pone.0007881.
64. Porter, M. E. (2002). Positive and negative effects of deletions and mutations within the 5' flanking sequences of Plasmodium falciparum DNA polymerase delta. Mol. Biochem. Parasitol. 122, 9-19. doi: 10.1016/S0166-6851(02)00064-6.
65. Ramakrishnan, C., Rademacher, A., Soichot, J., Costa, G., Waters, A. P., Janse, C. J., et al. (2012). Salivary gland-specific P. berghei reporter lines enable rapid evaluation of tissue-specific sporozoite loads in mosquitoes. PLoS ONE. 7:e36376. doi: 10.1371/journal.pone.0036376.
66. Ramalhete, C., da Cruz, F. P., Lopes, D., Mulhovo, S., Rosário, V. E., Prudêncio, M., et al. (2011). Triterpenoids as inhibitors of erythrocytic and liver stages of Plasmodium infections. Bioorg. Med. Chem. 19, 7474-7481. doi: 10.1016/j.bmc.2011.10.044.
67. Ramalhete, C., da Cruz, F. P., Mulhovo, S., Sousa, I. J., Fernandes, M. X., Prudêncio, M., et al. (2014). Dual-stage triterpenoids from an African medicinal plant targeting the malaria parasite. Bioorg. Med. Chem. 22, 3887-3890. doi: 10.1016/j.bmc.2014.06.019.
68. Sack, B. K., Miller, J. L., Vaughan, A. M., Douglass, A., Kaushansky, A., Mikolajczak, S., et al. (2014). Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect. Immun. 82, 808-817. doi: 10.1128/IAI.01249-13.
69. Smale, S. T. (2010). Luciferase assay. Cold Spring Harb. Protoc. 2010. doi: 10.1101/pdb.prot5421.
70. Spaccapelo, R., Janse, C. J., Caterbi, S., Franke-Fayard, B., Bonilla, J. A., Syphard, L. M., et al. (2010). Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria. Am. J. Pathol. 176, 205-217. doi: 10.2353/ajpath.2010.090504.
71. Stone, W. J., Churcher, T. S., Graumans, W., van Gemert, G. J., Vos, M. W., Lanke, K. H., et al. (2014). A scalable assessment of Plasmodium falciparum transmission in the standard membrane-feeding assay, using transgenic parasites expressing green fluorescent protein-luciferase. J. Infect. Dis. 210, 1456-1463. doi: 10.1093/infdis/jiu271.
72. Thorne, N., Shen, M., Lea, W. A., Simeonov, A., Lovell, S., Auld, D. S., et al. (2012). Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter. Chem. Biol. 19, 1060-1072. doi: 10.1016/j.chembiol.2012.07.015.
73. Van Reet, N., Van de Vyver, H., Pyana, P. P., Van der Linden, A. M., and Büscher, P. (2014). A panel of Trypanosoma brucei strains tagged with blue and red-shifted luciferases for bioluminescent imaging in murine infection models. PLoS Negl. Trop. Dis. 8:e3054. doi: 10.1371/journal.pntd.0003054.
74. van Schaijk, B. C., Ploemen, I. H., Annoura, T., Vos, M. W., Lander, F., van Gemert, G. J., et al. (2014). A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites. Elife 19:3. doi: 10.7554/eLife.03582.
75. Vaughan, A. M., Mikolajczak, S. A., Camargo, N., Lakshmanan, V., Kennedy, M., Lindner, S. E., et al. (2012). A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. Mol. Biochem. Parasitol. 186, 143-147. doi: 10.1016/j.molbiopara.2012.10.004.
76. Waller, K. L., Muhle, R. A., Ursos, L. M., Horrocks, P., Verdier-Pinard, D., Sidhu, A. B., et al. (2003). Chloroquine resistance modulated in vitro by expression levels of the Plasmodium falciparum chloroquine resistance transporter. J. Biol. Chem. 278, 33593-33601. doi: 10.1074/jbc.M302215200.
77. Waters, A. P., Thomas, A. W., van Dijk, M. R., and Janse, C. J. (1997). Transfection of malaria parasites. Methods 13, 134-147. doi: 10.1006/meth.1997.0506.
78. Weiwer, M., Mulrooney, C., Massi, D., Heidebrecht, R., Wiegand, R., Lukens, A. K., et al. (2011). ML238: An Antimalarial Small Molecule of a Unique Structural Class. Probe Reports. Bethesda, MD: NIH Molecular Libraries Program.
79. White, N. J., Pukrittayakamee, S., Hien, T. T., Faiz, M. A., Mokuolu, O. A., and Dondorp, A. M. (2014). Malaria. Lancet 383, 723-735. doi: 10.1016/S0140-6736(13)60024-0.
80. World Health Organization. (2013). World Malaria Report. Available at: http://www.who.int/malaria/publications/worldmalariareport/en/.
81. Zhang, X., Tolzmann, C. A., Melcher, M., Haas, B. J., Gardner, M. J., Smith, J. D., et al. (2011). Branch point identification and sequence requirements for intron splicing in Plasmodium falciparum. Eukaryot Cell. 10, 1422-1428. doi: 10.1128/EC.05193-11.
82. Zuzarte-Luis, V., Sales-Dias, J., and Mota, M. M. (2014). Simple, sensitive and quantitative bioluminescence assay for determination of malaria pre-patent period. Malar. J. 13, 15. doi: 10.1186/1475-2875-13-15.